Literature DB >> 33410105

Current Concepts and Controversies in the Management of REM Sleep Behavior Disorder.

E Matar1,2, S J McCarter3,4, E K St Louis3,4,5, S J G Lewis6,7.   

Abstract

Rapid eye movement (REM) sleep behavior disorder (RBD) is characterized by dream enactment and the loss of muscle atonia during REM sleep, known as REM sleep without atonia (RSWA). RBD can result in significant injuries, prompting patients to seek medical attention. However, in others, it may present only as non-violent behaviors noted as an incidental finding during polysomnography (PSG). RBD typically occurs in the context of synuclein-based neurodegenerative disorders but can also be seen accompanying brain lesions and be exacerbated by medications, particularly antidepressants. There is also an increasing appreciation regarding isolated or idiopathic RBD (iRBD). Symptomatic treatment of RBD is a priority to prevent injurious complications, with usual choices being melatonin or clonazepam. The discovery that iRBD represents a prodromal stage of incurable synucleinopathies has galvanized the research community into delineating the pathophysiology of RBD and defining biomarkers of neurodegeneration that will facilitate future disease-modifying trials in iRBD. Despite many advances, there has been no progress in available symptomatic or neuroprotective therapies for RBD, with recent negative trials highlighting several challenges that need to be addressed to prepare for definitive therapeutic trials for patients with this disorder. These challenges relate to i) the diagnostic and screening strategies applied to RBD, ii) the limited evidence base for symptomatic therapies, (iii) the existence of possible subtypes of RBD, (iv) the relevance of triggering medications, (v) the absence of objective markers of severity, (vi) the optimal design of disease-modifying trials, and vii) the implications around disclosing the risk of future neurodegeneration in otherwise healthy individuals. Here, we review the current concepts in the therapeutics of RBD as it relates to the above challenges and identify pertinent research questions to be addressed by future work.

Entities:  

Keywords:  REM sleep behavior disorder; disease-modifying; neurodegeneration; sleep; treatment

Mesh:

Substances:

Year:  2021        PMID: 33410105      PMCID: PMC8116413          DOI: 10.1007/s13311-020-00983-7

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  150 in total

1.  REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study.

Authors:  C Scaglione; L Vignatelli; G Plazzi; R Marchese; A Negrotti; G Rizzo; G Lopane; L Bassein; M Maestri; S Bernardini; P Martinelli; G Abbruzzese; S Calzetti; U Bonuccelli; F Provini; G Coccagna
Journal:  Neurol Sci       Date:  2005-02       Impact factor: 3.307

Review 2.  Prevalence of REM sleep behavior disorder in multiple system atrophy: a multicenter study and meta-analysis.

Authors:  Jose-Alberto Palma; Clara Fernandez-Cordon; Elizabeth A Coon; Phillip A Low; Mitchell G Miglis; Safwan Jaradeh; Arijit K Bhaumik; Praveen Dayalu; Elena Urrestarazu; Jorge Iriarte; Italo Biaggioni; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2015-03-05       Impact factor: 4.435

Review 3.  Idiopathic REM sleep behaviour disorder and neurodegeneration - an update.

Authors:  Birgit Högl; Ambra Stefani; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2017-11-24       Impact factor: 42.937

4.  Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.

Authors:  B F Boeve; M H Silber; T J Ferman; J A Lucas; J E Parisi
Journal:  Mov Disord       Date:  2001-07       Impact factor: 10.338

5.  The association between narcolepsy and REM behavior disorder (RBD).

Authors:  S Nightingale; J C Orgill; I O Ebrahim; S F de Lacy; S Agrawal; A J Williams
Journal:  Sleep Med       Date:  2005-05       Impact factor: 3.492

Review 6.  Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions.

Authors:  Alex Iranzo; Joan Santamaria; Eduardo Tolosa
Journal:  Lancet Neurol       Date:  2016-04       Impact factor: 44.182

7.  Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.

Authors:  B F Boeve; M H Silber; T J Ferman; S C Lin; E E Benarroch; A M Schmeichel; J E Ahlskog; R J Caselli; S Jacobson; M Sabbagh; C Adler; B Woodruff; T G Beach; A Iranzo; E Gelpi; J Santamaria; E Tolosa; C Singer; D C Mash; C Luca; I Arnulf; C Duyckaerts; C H Schenck; M W Mahowald; Y Dauvilliers; N R Graff-Radford; Z K Wszolek; J E Parisi; B Dugger; M E Murray; D W Dickson
Journal:  Sleep Med       Date:  2013-03-07       Impact factor: 3.492

8.  The Clinical Phenotype of Idiopathic Rapid Eye Movement Sleep Behavior Disorder at Presentation: A Study in 203 Consecutive Patients.

Authors:  Ana Fernández-Arcos; Alex Iranzo; Mónica Serradell; Carles Gaig; Joan Santamaria
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

9.  Chronic behavioral disorders of human REM sleep: a new category of parasomnia.

Authors:  C H Schenck; S R Bundlie; M G Ettinger; M W Mahowald
Journal:  Sleep       Date:  1986-06       Impact factor: 5.849

10.  REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease.

Authors:  J F Gagnon; M A Bédard; M L Fantini; D Petit; M Panisset; S Rompré; J Carrier; J Montplaisir
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

View more
  3 in total

Review 1.  Sleep Neurology's Toolkit at the Crossroads: Challenges and Opportunities in Neurotherapeutics Lost and Found in Translation.

Authors:  Erik K St Louis; Aleksandar Videnovic
Journal:  Neurotherapeutics       Date:  2021-04-05       Impact factor: 7.620

2.  Predictors of dream enactment behavior among medical students: The case of the University of Gondar, Ethiopia.

Authors:  Baye Dagnew; Mengistie Diress; Mihret Getnet; Mohammed Abdu Seid; Sofonias Addis Fekadu; Yibeltal Yismaw Gela; Yigizie Yeshaw; Yitayeh Belsti; Yonas Akalu
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

Review 3.  Isolated REM sleep behaviour disorder: current diagnostic procedures and emerging new technologies.

Authors:  Samantha Bramich; Anna King; Maneesh Kuruvilla; Sharon L Naismith; Alastair Noyce; Jane Alty
Journal:  J Neurol       Date:  2022-06-24       Impact factor: 6.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.